ACTILYSE 2 mg, powder for solution for injection and infusion 5 bottles
Active ingredients: Alteplase
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injection or infusion5 bottlesvoie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACTILYSE 2 mg, poudre pour solution injectable et perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- voie extracorporelle autre
- Presentation description
- 5 flacon(s) en verre
- Marketing authorisation holder
- BOEHRINGER INGELHEIM FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jul 2011
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67177673CIP75741942CIP133400957419424Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALTÉPLASEpoudre | 2 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.